BORGHESI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 11.589
EU - Europa 8.054
AS - Asia 7.814
AF - Africa 717
SA - Sud America 478
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 28.668
Nazione #
US - Stati Uniti d'America 11.458
SG - Singapore 2.479
GB - Regno Unito 2.354
CN - Cina 2.129
VN - Vietnam 1.759
IT - Italia 1.290
DE - Germania 1.227
SE - Svezia 799
HK - Hong Kong 623
RU - Federazione Russa 530
IN - India 466
FR - Francia 414
BR - Brasile 361
IE - Irlanda 330
NL - Olanda 264
TG - Togo 245
ZA - Sudafrica 221
EE - Estonia 197
UA - Ucraina 171
CI - Costa d'Avorio 119
JO - Giordania 119
FI - Finlandia 109
CA - Canada 88
NG - Nigeria 76
BG - Bulgaria 66
CH - Svizzera 64
AR - Argentina 62
BE - Belgio 59
IR - Iran 49
JP - Giappone 48
AT - Austria 34
PL - Polonia 33
MX - Messico 29
ES - Italia 28
ID - Indonesia 28
LT - Lituania 27
BD - Bangladesh 22
KR - Corea 22
SC - Seychelles 20
EC - Ecuador 18
GR - Grecia 16
CL - Cile 14
RO - Romania 14
UZ - Uzbekistan 11
TR - Turchia 10
AU - Australia 9
CZ - Repubblica Ceca 7
IQ - Iraq 7
PK - Pakistan 7
MA - Marocco 6
TW - Taiwan 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
PE - Perù 5
UY - Uruguay 5
VE - Venezuela 5
DZ - Algeria 4
ET - Etiopia 4
HR - Croazia 4
LB - Libano 4
MY - Malesia 4
PY - Paraguay 4
SA - Arabia Saudita 4
SN - Senegal 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
EG - Egitto 3
GH - Ghana 3
KE - Kenya 3
RS - Serbia 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BF - Burkina Faso 2
BZ - Belize 2
HN - Honduras 2
IL - Israele 2
KZ - Kazakistan 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AQ - Antartide 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
GA - Gabon 1
GT - Guatemala 1
KH - Cambogia 1
MK - Macedonia 1
MR - Mauritania 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
SV - El Salvador 1
Totale 28.665
Città #
Southend 2.145
Singapore 1.570
Ashburn 1.376
Fairfield 1.139
Chandler 1.101
Houston 634
Hong Kong 617
Wilmington 581
Woodbridge 569
Seattle 563
Dong Ket 500
Santa Clara 467
Princeton 453
Cambridge 434
Ann Arbor 341
Dublin 327
Beijing 321
Lomé 245
Boardman 240
Nanjing 231
Westminster 223
Bologna 206
Padova 203
Berlin 189
Dallas 166
Jinan 150
New York 134
Shenyang 130
Ho Chi Minh City 129
Saint Petersburg 123
Los Angeles 121
Abidjan 119
Amman 119
Dearborn 106
Medford 105
Bremen 98
Redondo Beach 97
Hanoi 95
Hebei 89
Buffalo 88
Changsha 83
Turin 81
Milan 80
Helsinki 79
San Diego 72
Abeokuta 71
Frankfurt am Main 70
Munich 70
Nanchang 68
Tianjin 63
Guangzhou 60
Sofia 60
Florence 58
London 58
Brussels 55
Redwood City 52
Toronto 50
Jiaxing 45
Zhengzhou 45
Tokyo 42
Hangzhou 41
Düsseldorf 40
Yubileyny 40
Haikou 39
Hefei 39
São Paulo 38
Bern 37
Frattamaggiore 37
Falls Church 32
Ningbo 31
Mountain View 30
Jacksonville 29
Norwalk 29
Olalla 29
Falkenstein 28
Fuzhou 27
Mülheim 27
Phoenix 27
Taiyuan 27
Taizhou 27
Turku 27
Chicago 26
Redmond 25
Nuremberg 24
Leawood 23
Shanghai 23
Brooklyn 22
Lanzhou 21
Amsterdam 20
Rome 20
Zanjan 20
Moscow 19
Seoul 19
Haiphong 16
San Jose 16
Stockholm 16
Vienna 16
Warsaw 16
Da Nang 14
Kerkrade 14
Totale 18.857
Nome #
3D reconstruction and physical renal model to improve percutaneous punture during PNL 379
Adverse Features and Competing Risk Mortality in Patients With High-Risk Prostate Cancer 248
ANALISI DELLE COMPLICANZE INTRAOPERATORIE E DELLE CONSEGUENZE SUL DECORSO POSTOPERATORIO DOPO NEFRECTOMIA PARZIALE. STUDIO PROSPETTICO MULTICENTRICO OSSERVAZIONALE RECORD1. 232
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study. 226
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 216
Accuracy of [11C] Choline positron emission tomography/computed tomography in preoperative staging in patients with bladder cancer referred to radical cistectomy: comparison with conventional computed tomography 215
ACCURACY OF PET/CT WITH 11-C-CHOLINE IN THE RESTAGING OF RECURRENT PROSTATE CANCER PATIENTS WITH A SINGLE LESION AT BONE SCINTIGRAPHY 214
Sex-related penile fracture with complete urethral rupture: A case report and review of the literature 213
Can the multiphasic computed tomography (CT) scan be useful in the clinical management of small renal masses? 212
Accuracy of 18f-facbc (anti1-amino-3-18f-fluorocyclobutane-1-carboxylic acid) in prostate cancer relapse: Results of a prospective trial 207
Active surveillance for clinically localized renal tumors: An updated review of current indications and clinical outcomes 203
Complications After Systematic, Random, and Image-guided Prostate Biopsy 200
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients. 196
11C-Choline PET/CT in castration-resistant prostate cancer patients treated with docetaxel 194
CHIRURGIA MININVASIVA PER IL TRATTAMENTO DELLA LITIASI DELL’ALTA VIA ESCRETRICE: RISULTATI PRELIMINARI DI CONFRONTO TRA TECNICA ROBOT-ASSISTITA E LAPAROSCOPICA 194
Can testis-sparing surgery for small testicular masses be considered a valid alternative to radical orchiectomy? A prospective single-center study 187
Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique 187
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. 185
68Ga-PSMA PET/CT for restaging prostate cancer after definitive therapy: Results of a prospective single-center trial 184
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS 182
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and mid-term follow-up 182
18F-FACBC PET/CT FOR NODAL STAGING IN HIGH RISK PROSTATE CANCER: PRELIMINARY DIAGNOSTIC ACCURACY ANALYSIS 182
10 YEARS ONCOLOGIC OUTCOMES OF Robot-assISTED RADICAL PROSTATECTOMY: A PROPENSITY-SCORE MATCH ANALYSIS COMPARED WITH OPEN APPROACH 178
The prognostic impact of tumour size on cancer-specific and overall survival among patients with pathologic t3a renal cell carcinoma 177
Can we consider eligible for active surveillance prostate cancer patients with biopsy Gleason 3+4 in only one core? Results of single center study after extensive central revision of histological specimens and midterm follow-up 177
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 177
ACCURATEZZA DELLA TC/PETCON 11-C-COLINA NELLA RISTADIAZIONE DEI PAZIENTI CON NEOPLASIA PROSTATICA RECIDIVA CON UNA SINGOLA LESIONE ALLA SCINTIGRAFIA OSSEA 176
The impact of a structured intensive modular training in the learning curve of robot assisted radical prostatectomy. 174
MRI DISPLAYS THE PROSTATIC CANCER ANATOMY AND IMPROVES THE BUNDLES MANAGEMENT BEFORE ROBOT ASSISTED RADICAL PROSTATECTOMY 172
How does 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography impact the management of patients with prostate cancer recurrence after surgery? 172
Perioperative complications and mortality after radical cystectomy when using a standardized reporting methodology. 170
The biopsy Gleason score 3+4 in a single core does not necessarily reflect an unfavourable pathological disease after radical prostatectomy in comparison with biopsy Gleason score 3+3: looking for larger selection criteria for active surveillance candidates 170
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 168
18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients 166
Holmium laser prostatectomy in a tertiary Italian center: A prospective cost analysis in comparison with bipolar TURP and open prostatectomy 166
ACCURATEZZA DIAGNOSTICA DI 18F-FACBC PET/CT VS 11C-COLINA PET/CT NEI PAZIENTI CON RECIDIVA BIOCHIMICA DOPO TRATTAMENTO RADICALE PER CARCINOMA PROSTATICO: STUDIO PROSPETTICO SU 100 PAZIENTI. 165
Fibrotic Adhesive Toxic-fat (F.A.T.): the association of fibrotic and adhesive perirenal fat with peri-operative outcomes of robot-assisted par tial nephrectomy (RAPN) 165
Compa rison of 18F-fluciclovine PET/CT with 11 C-Choline PET/CT for nodal staging in prostate cancer: a prospective study 165
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT 164
"In-bore" MRI-guided Prostate Biopsy Using an Endorectal Nonmagnetic Device: A Prospective Study of 70 Consecutive Patients 164
(68)Ga-PSMA-PET/CT-Guided Salvage Retroperitoneal Lymph Node Dissection for Disease Relapse After Radical Prostatectomy for Prostate Cancer 163
ANALISI DELLE COMPLICANZE POSTOPERATORIE E DEI FATTORI PREDITTIVI DOPO NEFRECTOMIA PARZIALE: STUDIO PROSPETTICO MULTICENTRICO OSSERVAZIONALE RECORD1 163
Can the multiphasic computed tomography be useful in the clinical management of small renal masses? 163
Three-dimensional digital reconstruction of renal model to guide preoperative planning of robot-assisted partial nephrectomy. 160
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high- risk prostate cancer 158
DUPLICE ENUCLEORESEZIONE RENALE ROBOTICA CON ACCESSO RETROPERITONEALE IN PAZIENTE CON PREGRESSA CHIRURGIA ADDOMINALE, TROMBOCITOPENIA CRONICA E CIRROSI EPATICA 156
Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guérin after transurethral resection of the bladder tumor. 155
The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancer. 153
TRIFECTA RATES IN A COHORT OF PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS AT LOW-INTERMEDIATE COMPLEXITY: A SINGLE-INSTITUTIONAL ANALYSIS 151
Nodal Occult Metastases in Intermediate- and High-Risk Prostate Cancer Patients Detected Using Serial Section, Immunohistochemistry, and Real-Time Reverse Transcriptase Polymerase Chain Reaction: Prospective Evaluation With Matched-Pair Analysis. 150
Preservation of the Internal Vesical Sphincter and Proximal Urethra During Retropubic Radical Prostatectomy may Improve Earlier Recovery of Continence in Selected Patients 150
NEFRECTOMIA PARZIALE ROBOTICA CON APPROCCIO RETROPERITONEALE A QUATTRO BRACCIA 150
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 150
Active surveillance for small renal masses diagnosed in elderly or comorbid patients: Looking for the best treatment strategy. 149
La nefrolitotrissia percutanea Tubeless nel trattamento della litiasi renale: studio retrospettivo di confronto con la nefrolitrotrissia percutanea standard in una coorte di 317 pazienti 147
Posterior muscle-fascial reconstruction and knotless urethro-neo bladder anastomosis during robot-assisted radical cystectomy: Description of the technique and its impact on urinary continence. 147
Can side-specific biopsy findings predict the side of nodal metastasis in clinically localized prostate cancer? Results from a multicenter prospective survey 146
VALUTAZIONE DELLA CONTINENZA URINARIA DOPO PROSTATECTOMIA RADICALE IN PAZIENTI SOTTOPOSTI A RIABILITAZIONE POST OPERATORIA DEL PAVIMENTO PELVICO: RISULTATI A CONFRONTO FRA TECNICA LAPAROTOMICA E LAPAROSCOPICA 146
Radiological evaluation by magnetic resonance of the ‘new anatomy’ of transsexual patients undergoing male to female sex reassignment surgery 145
18F-FACBC PET/CT VS. 11C-CHOLINE FOR THE DETECTION OF PROSTATE CANCER RELAPSE AFTER RADICAL TREATMENT 145
POSITRON-EMISSION TOMOGRAPHY IN IMAGING AND STAGING PROSTATE CANCER 144
Retroperitoneal Robot-Assisted Versus Open Partial Nephrectomy for cT1 Renal Tumors: A Matched-Pair Comparison of Perioperative and Early Oncological Outcomes. 144
Detection of nodal micro metastases with serial section, immunohistochemistry and real time-polymerase chain reaction in intermediate and high risk prostate cancer patients submitted to radical prostatectomy with extended pelvic lymph node dissection: A perspective study 144
PREOPERATIVE MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING AND NEUROVASCULAR BUNDLE MANAGEMENT: SURGICAL PLAN CHANGE IN COURSE OF Robot-assISTED RADICAL PROSTATECTOMY 143
Prognostic significance of positive surgical margins after radical prostatectomy for prostate cancer 142
Role of testis sparing surgery in the conservative management of small testicular masses: oncological and functional perspectives. 142
A PROSPECTIVE, MULTICENTER EVALUATION OF PREDICTIVE FACTORS FOR POSITIVE SURGICAL MARGINS AFTER NEPHRON SPARING SURGERY FOR RENAL CELL CARCINOMA: THE RECORD1 ITALIAN PROJECT 141
SURVIVAL, CONTINENCE AND POTENCY (SCP) RECOVERY AFTER RADICAL RETROPUBIC PROSTATECTOMY: A LONG-TERM COMBINED EVALUATION OF SURGICAL OUTCOMES 141
Retroperitoneal approach for robot-assisted partial nephrectomy: technique and early outcomes 141
Molecular diagnostic tools for the detection of nodal micrometastases in prostate cancer patients undergoing radical prostatectomy with extended pelvic lymph node dissection: a prospective study. 141
Patterns of positive surgical margins after open radical prostatectomy and their association with clinical recurrence 141
DETECTION OF NODAL MICRO-METASTASES WITH SERIAL SECTION, IMMUNOHISTOCHEMISTRY AND REAL TIME POLYMERASE CHAIN REACTION IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER PATIENTS SUBMITTED TO RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION: A PERSPECTIVE STUDY 141
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer. 141
SOPRAVVIVENZA CANCRO SPECIFICA NEI PAZIENTI SOTTOPOSTI A PROSTATECTOMIA RADICALE E MALATTIA AGGRESSIVA ALL’ESAME ISTOLOGICO DEFINITIVO. 140
PADUA and R.E.N.A.L. nephrometry scores correlate with perioperative outcomes of robot-assisted partial nephrectomy: analysis of the Vattikuti Global Quality Initiative in Robotic Urologic Surgery (GQI-RUS) database 140
Comparative analysis of surgical margins status in patients who underwent radical retropubic prostatectomy or laparoscopic radical prostatectomy for prostate cancer: a large, single-institution experience 139
MULTIPLA NEFRECTOMIA PARZIALE ROBOTICA "CLAMPLESS", CON L'AUSILIO DI ECOGRAFIA INTRAOPERATORIA (TILEPRO®) IN PAZIENTE MONORENE CHIRURGICO 139
ElectRomagnetic synchronized real-time system for MRI-TRUS fusion targeted biopsy of prostate (Toshiba Aplio 500Tm) in a heterogeneous pa tients cohort: results and compa rison with systematic biopsy 139
Patterns of positive surgical margins after surgery in prostate cancer pa tients and their association with clinical recurrence 138
Small Renal Masses Managed With Active Surveillance: Predictors of Tumor Growth Rate After Long-Term Follow-Up. 138
Survival, continence and potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes 138
THE VALUE OF HISTOLOGICAL REVISION OF BIOPSY CORES IN PATIENTS SUITABLE FOR ACTIVE SURVEILLANCE: COMPARISON WITH SURGICAL SPECIMENS AFTER RADICAL PROSTATECTOMY AND CLINICAL FOLLOW-UP 137
Survival, Continence and Potency (SCP) recovery after radical retropubic prostatectomy: A long-term combined evaluation of surgical outcomes. 137
The Prognostic Impact of Tumor Size on Cancer-Specific and Overall Survival Among Patients With Pathologic T3a Renal Cell Carcinoma 136
Differing Risk of Cancer Death Among Patients With Pathologic T3a Renal Cell Carcinoma: Identification of Risk Categories According to Fat Infiltration and Renal Vein Thrombosis. 135
Preoperative Staging With 11C-Choline PET/CT Is Adequately Accurate in Patients With Very High-Risk Prostate Cancer. 135
LYMPH NODE DENSITY IN NODE-POSITIVE PATIENTS TREATED WITH RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 134
QUAL'È L' IMPATTO DELL'ESTENSIONE DELLA LINFECTOMIA PELVICA ESEGUITA IN CORSO DI PROSTATECTOMIA RADICALE PER CARCINOMA PROSTATICO SULLA RIPRESA BIOCHIMICA NEI PAZIENTI PTXN0? 134
[Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients]. 133
The value of histological revision of biopsy cores in patients suitable for active surveillance: comparison with surgical specimens after radical prostatectomy and clinical follow-up. 133
PROGNOSTIC SIGNIFICANCE OF POSITIVE SURGICAL MARGINS AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER 133
TESTIS SPARING SURGERY FOR SMALL TESTICULAR MASSES: SINGLE CENTER RETROSPECTIVE ANALYSIS 133
DIAGNOSTIC ACCURACY OF 11C-CHOLINE PET/CT IN COMPARISON WITH CONTRASTENHANCED CT IN THE PREOPERATIVE LYMPH-NODE STAGING OF BLADDER CANCER USING THE PATHOLOGICAL SPECIMENS AS REFERENCE STANDARD 132
A new preperitoneal technique for the repair of inguinal hernia during prostatic surgery: first 153 procedures. 131
POSSIAMO INCLUDERE NELLA SORVEGLIANZA ATTIVA PER NEOPLASIA PROSTATICA, PAZIENTI CON CGS 3+4 IN UN UNICO PRELIEVO BIOPTICO? RISULTATI A MEDIO TERMINE DI UN SINGOLO CENTRO DOPO REVISIONE ISTOLOGICA SISTEMATICA DEI PRELIEVI BIOPTICI E DEI REPERTI OPERATORI 131
IMPATTO ECONOMICO DELLA TERAPIA CHIRURGICA A CIELO APERTO ED ENDOSCOPICA PER L’IPERTROFIA PROSTATICA BENIGNA: ANALISI E CONFRONTO DEI COSTI SOSTENUTI NEL 2015 DA UN CENTRO DI TERZO LIVELLO 131
PERIOPERATIVE RESULTS , EARLY ONCOLOGICAL OUTCOMES AND TRIFECTA RATE IN PATIENTS UNDERGOING OPEN, LAPAROSCOPIC AND ROBOT-ASSISTED PARTI AL NEPHRECTOMY FOR CLINICALLY LOCALIZED RENAL TUMORS: A SINGLE INSTITUTIONAL ANALYSIS 131
State-of-the-art imaging techniques in the management of preoperative staging and re-staging of prostate cancer. 131
Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database 131
Warm ischemia time and postoperative complications after partial nephrectomy for renal cell carcinoma. 130
Totale 16.236
Categoria #
all - tutte 76.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.849


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.846 0 0 0 0 0 60 66 87 326 107 80 1.120
2021/20224.152 809 137 203 235 407 222 63 249 145 230 794 658
2022/20234.428 434 811 254 603 263 298 128 233 791 188 302 123
2023/20241.106 109 197 38 120 94 221 71 74 24 83 27 48
2024/20254.326 167 721 366 355 701 279 265 120 28 347 117 860
2025/20264.533 794 576 918 567 1.204 474 0 0 0 0 0 0
Totale 29.279